BridgeMD
New treatment option for Gastric Cancer (Diagnosis)
Official title TAIC FOLFOX for Locally Advanced G/GEJA
ClinicalTrials.gov ID: NCT07655024
What this study is testing
What is FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)?
FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for gastric cancer (diagnosis).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Gastric cancer is the fifth most common malignancy worldwide in terms of both incidence and mortality. The majority of cases are diagnosed at advanced stage-often presenting with severe complications such as malignant stricture, obstruction, bleeding, and cancer-related malnutrition-which impinge on quality of life and survival outcomes.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Pathologically diagnosed with G/GEJA
- Confirmed by the surgeon as initially unresectable advanced G/GEJC
- Contraindicated to surgery due to frailty or comorbidities
- Expected survival period ≥ 3 months
You likely can't join if
- Primary malignant tumors
- Gastrointestinal obstruction caused by lesions in the distal stomach, duodenum, pancreas or other organs
- Acute infection, severe liver or kidney dysfunction or coagulation disorder
- Allergic to the drugs or with mental disorders
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.